Lineage Cell Therapeutics
LCTX
$1.05
Share price
-7.08%
Change (1 day)
-19.85%
Change (1 year)
Categories
Operating Margin for Lineage Cell Therapeutics (LCTX)
Operating Margin as of May 2024 (TTM): -1,110.62%
According to Lineage Cell Therapeutics 's latest financial reports and stock price the company's current Operating Margin is -1,110.62%. At the end of 2021 the company had an Operating Margin of -1,110.63%.
Operating Margin history for Lineage Cell Therapeutics from 2001 to 2022
Operating Margin at the end of each year
| Year | Operating Margin | Change |
|---|---|---|
| 2021 | -1,110.63% | -60.84% |
| 2020 | -2,836.22% | 117.94% |
| 2019 | -1,301.35% | -60.9% |
| 2018 | -3,328.39% | 156.11% |
| 2017 | -1,299.61% | -257.17% |
| 2016 | 826.87% | -133.44% |
| 2015 | -2,472.38% | -5.93% |
| 2014 | -2,628.21% | 33.82% |
| 2013 | -1,963.99% | 31.38% |
| 2012 | -1,494.85% | 248.37% |
| 2011 | -429.10% | 60.29% |
| 2010 | -267.70% | 46.4% |
| 2009 | -182.86% | -2.58% |
| 2008 | -187.70% | 60.64% |
| 2007 | -116.85% | -22.49% |
| 2006 | -150.76% | -32.54% |
| 2005 | -223.47% | -21.86% |
| 2004 | -286.00% | -5.83% |
| 2003 | -303.70% | -42.23% |
| 2002 | -525.72% | -77.15% |
| 2001 | -2,300.33% |
Operating Margin for similar companies or competitors
| Company | Operating Margin | Operating Margin differencediff. | Country |
|---|---|---|---|
 ORIC Pharmaceuticals
ORIC | 0.00% | N/A | 🇺🇸 USA |
What is a company's Operating Margin
The operating margin is a key indicator to assess the profitability of a company. Higher operating margins are generaly better as they show that a company is able to sell its products or services for much more than their production costs. The operating margin is calculated by dividing a company's earnings by its revenue.